Description
Enfiera Injection belongs to a class of medicines called monoclonal antibodies used in the treatment of non-Hodgkin’s disease and chronic lymphocytic leukaemia. This medicine is also used in treating rheumatoid arthritis in combination with methotrexate and granulomatosis in combination with glucocorticoids. It is also used to treat Pemphigus Vulgaris (PV) and mature B-cell acute leukaemia (B-AL).
Additional information
| Brand | Enfiera |
|---|---|
| Generic name | Rituximab solution for infusion |
| Form | Parenteral |
| Strength | 500mg/50mL |
| Manufacturer | Zydus |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.